Wednesday, November 18, 2026
Data from SEC filings, checked daily
My DeskFree
Public filings, plainly told
CEO Joseph Todisco buys $391,200 of CorMed
Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Data updated Nov 18, 2026·New filings added every weekday·Weekly prices as of Nov 20·What changed·
Insider purchase · Form 4 · Nov 16, 2026

CEO Joseph Todisco buys $391,200 of CorMedix Inc. (CRMD)

Joseph Todisco, chief executive, bought $391,200 of stock after a 38.1% fall. WallStPal Score 70.

70
WallStPal ScoreHow much this purchase says, from 0 to 100. How it works

Joseph Todisco, chief executive of CorMedix Inc., bought 80,000 shares on the open market on November 13, 2026 at an average of $4.89 a share, for a total of $391,200. The purchase was reported to the SEC on Form 4 on November 16, 2026.

It raised their holding by 10%, to 854,749 shares.

The purchase came after a fall: CorMedix Inc. stock was down 38.1% over the 13 weeks before.

It is Joseph Todisco's first purchase of CRMD in at least 1 year of our records.

In the 12 months up to this filing, CorMedix Inc. insiders reported 1 open-market purchase and 8 sales.

WallStPal Score: 70 out of 100, because of raised their holding by 10%; outside their usual buying pattern; first purchase in 1+ year; the stock had fallen 38.1% in the 13 weeks before; bought by a top executive.

It is too soon to say how the stock did afterward. This page will update as prices come in.

Our read

The first open-market purchase by Joseph Todisco in our records, made after a 38.1% fall in 13 weeks, a setup where insider buying has historically mattered most. Insiders buy for many reasons and can be wrong; one purchase is a reason to look closer, not a reason to buy.

Source: SEC Form 4 filing ↗. This story was written automatically from the filing and weekly price data. Information, not investment advice.

Examples

The only earlier insider purchase of CorMedix Inc. in our records with a three-month result was by Myron Kaplan on October 23, 2025 ($275,500); the stock moved -38.5% over the following three months. One past purchase is not a pattern.

Explain it like I'm 13

Joseph Todisco helps run CorMedix Inc.. Spending $391,200 of their own money on the company's stock is like a coach buying a big stack of tickets to their own team's games: it suggests they think the team will do well. It is not a promise, and insiders can be wrong.

More: all CRMD insider trades

Sources

  1. Form 4: Joseph Todisco, purchase of CRMD · filed 2026-11-16
  2. Form 4: Janet Dillione, sale · filed 2026-01-22
  3. Form 4: Alan W. Dunton, sale · filed 2026-01-02
  4. Form 4: Joseph Todisco, sale · filed 2025-12-19
  5. Form 4: Janet Dillione, sale · filed 2025-12-11

The purchase filing and the other most recent Form 4 filings for the same company.

Report an error

Tell us what looks wrong on this page. We check every report against the original filing and fix mistakes on our corrections page.

Share this trade
XTelegram
My Desk · free

Sign in to follow

Follow stocks, members of Congress, famous investors and funds, and see what's new each time you come back.